Nasdaq GlobeNewswire

Appian Announces “The Appian Guarantee”

Del

First Project Delivered in just 8 Weeks, Providing Rapid Path to High Productivity with Appian Cloud Platform

RESTON, Va., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN), an enterprise low-code and business process management platform provider, today announced The Appian Guarantee. The Guarantee establishes first project delivery in just 8 weeks for new Appian customers deploying in the Appian Cloud. This accelerated timeline, a first for the low-code platform market, demonstrates Appian’s commitment to bring customers to high productivity quickly.

Appian provides a platform for building enterprise software applications that is rated #1 in time-to-value and #1 in customer satisfaction by industry analysts and end-users. With Appian, organizations around the world create custom and complex software applications up to 20x faster and the Appian Guarantee further demonstrates Appian’s commitment to deliver software applications quickly in order to meet the ever-changing demands on the business.

The Appian Guarantee is only possible due to Appian’s unique combination of enterprise low-code development speed with the power of intelligent automation. Building powerful business solutions faster means Appian customers get to market first, improve customer experience, optimize internal operations, and achieve value faster. The Appian Guarantee ensures that anyone technical can be trained as an Appian developer in 2 weeks, and also provides organizations with a path for long-term success.

Under the Appian Guarantee, we deliver:

 

  • A focused 8-week delivery period for your first application project
  • Clearly-documented guidelines to ensure successful delivery
  • Full use of Appian standard features
  • Collaborative application design
  • Project implementation and best practices
  • Deployment guidelines and more

“With Appian, we delivered 9 key risk mitigating applications in 18 months. We built our first application in about 6 weeks. Now we’re at the point where we can build an application in a day,” said Denise Knabjian, First Vice President of Process Innovation at OCC (Options Clearing Corporation), the world's largest equity derivatives clearing organization and a federally-designated Systemically Important Financial Market Utility. (See video at https://www.youtube.com/watch?v=U3Dw5XQTyUc).

The Appian Guarantee is supported by KPMG LLP and other strategic Appian partners.

“Our clients are looking to speed up application development and increase productivity,” said Todd Lohr, principal, Intelligent Automation practice leader, KPMG. “Enterprise low-code platforms like Appian help make this a possibility, and can transform the way our clients are able to approach digital transformation. We are excited to deliver on what our clients are looking for – high-value, rapid enterprise application development that helps position them with a competitive market advantage.”

Customers using Appian Cloud are able to build, deploy and scale powerful business applications within the secure Appian Cloud environment. The benefits of Appian Cloud include low startup costs, fast deployment, enterprise-grade security and reliability, predictable cost structures and rapid return-on-investment. The platform provides strategic advantage in executing digital transformation, and is currently leveraged by top organizations around the world across a variety of industries including financial services, insurance, healthcare, life sciences, public sector, and others.

“The Appian Guarantee exists because Appian is easy to use, and easy to get value from. We want our customers to understand that and take comfort. Though our product is powerful, Appian maintains a dedication to simplicity. It's this latter focus that drives the Appian Guarantee,” said Matt Calkins, CEO at Appian.

For more information about the Appian Guarantee and program eligibility requirements and restrictions, visit: https://www.appian.com/company/appian-guarantee/

About Appian
Appian provides a software development platform that combines intelligent automation and enterprise low-code development to rapidly deliver powerful business applications. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk and compliance.

Forward-Looking Statements

This press release includes forward-looking statements. All statements contained in this press release other than statements of historical facts, including statements regarding delivery of projects in a definite timeline, creating applications up to 20 times faster, training anyone to be an Appian developer in two weeks, support for the Appian Guarantee by strategic Appian partners, and the use of the Appian Cloud to build, deploy and scale applications within the secure Appian Cloud environment, are forward-looking statements. The words "anticipate," believe," "continue," "estimate," "expect," "intend," "may," "will" and similar expressions are intended to identify forward-looking statements. Appian has based these forward-looking statements on its current expectations and projections about future events and financial trends that Appian believes may affect its financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to a number of risks and uncertainties, including the risks and uncertainties associated with customer satisfaction with our deployment services, Appian’s security measures, Appian’s need to continue to innovate on our platform, satisfaction with our third party partners services, the performance of our platform, Appian’s strategic relationships with third parties, the need for Appian to continue to invest in its network and infrastructure, Appian’s need to offer high-quality support, and the additional risks and uncertainties set forth in the "Risk Factors" section of Appian’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission on February 23, 2018 and other reports that Appian has filed with the Securities and Exchange Commission.  Moreover, Appian operates in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for Appian’s management to predict all risks, nor can Appian assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements Appian may make. In light of these risks, uncertainties and assumptions, Appian cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. Appian is under no duty to update any of these forward-looking statements after the date of this press release to conform these statements to actual results or revised expectations, except as required by law.

For Information Contact:
Nicole Greggs
Director of Media Relations
+1 703-260-7868 

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

WillScot Announces Closing of Warrant Exchange Offer11.12.2018 22:05Pressemelding

BALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the closing of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants issued in 2015 (the “Warrants”). Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the closing of the Exchange Offer on December 11, 2018, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximately 89% of the public warrants, and approximately 100,000 Warrants tendered were private warrant

DoubleVerify and InMobi Unite to Combat Mobile App Fraud11.12.2018 18:02Pressemelding

Partnership brings mobile app fraud prevention to advertisers globally NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DoubleVerify ("DV"), the leading independent provider of marketing measurement software and analytics, today announced a partnership with InMobi, a global provider of enterprise platforms for marketers. As part of the partnership, DoubleVerify will provide always-on fraud filtering and measurement for mobile in-app advertising campaigns across the InMobi Exchange globally. The integration with InMobi covers pre-bid targeting for all InMobi Exchange impressions within the leading mobile in-app platform, as well as monitoring of post-bid fraud activity, such as spoofing – enabling InMobi to continuously refine the quality of its mobile ad inventory. “DV’s partnership with InMobi demonstrates our commitment to provide consistent, comprehensive quality coverage for global brand advertisers,” said Matt McLaughlin, COO at DoubleVerify. “With ad spend increasingly concentrated in

Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform11.12.2018 15:00Pressemelding

Groundbreaking multispectral data acquisition and network segmentation capabilities provide deeper OT network visibility and reduce risk for industrial enterprises and critical infrastructure providers NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in operational technology (OT) network protection, today announced several significant enhancements to its award-winning Continuous Threat Detection product and technology integrations with several leading industrial automation, network infrastructure and cybersecurity providers. Already the industry’s most complete industrial control systems (ICS) cybersecurity platform, this release incorporates new functionality to provide even more “extreme” visibility into ICS networks and help industrial enterprises decrease the risk of a cyberattack. The latest release of Claroty Continuous Threat Detection provides a large number of significant enhancements including: Virtual Zones and OT Network Segmentation – an innovative approach

INN Launches Battery Metals Channel11.12.2018 15:00Pressemelding

The new battery metals channel is designed to educate investors with original content and expert insight on the growing battery metals industry. VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Investing News Network (INN) announces the launch of its battery metals channel. Responding to the growth and evolution of the battery metals market, this channel will host news, educational content and expert opinions on the lithium, cobalt, graphite, vanadium and manganese market segments. “INN has been a trusted source of information on the lithium, cobalt, graphite, vanadium and manganese markets for nearly a decade, and is excited to bring these sectors together under the battery metals umbrella,” said Nick Smith, CEO and publisher at INN. “Through connections with experts, our leading team of experienced writers creates original, insightful content on battery metals. INN educates investors in the industry by providing information they may never have access to on their own,” S

Galimedix Therapeutics Appoints Industry Veteran, Hermann Russ, M.D., Ph.D., Chief Scientific Officer11.12.2018 14:30Pressemelding

KENSINGTON, Md. and SHORASHIM, Israel, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, announced the appointment of Hermann Russ, M.D., Ph.D., as its chief scientific officer, effective December 1, 2018. Dr. Russ invented the use of the company’s lead molecule GAL-101/MRZ-99030 for the treatment of degenerative diseases of the retina, including glaucoma and dry macular degeneration. He is also co-inventor of the so-called “trigger effect” of GAL-101/MRZ-99030 and GAL-102/MRZ 14042, which is a unique reverse prion-like self-propagation mechanism of action important for the company’s eye drop and oral treatment regimens. “We are gratified that Dr. Russ is joining the Galimedix management team, as his knowledge in the field, as well as intimate experience with the compound, have already proven instrumental in the development of our company to date,” commented Andrew Pearlman, Ph.D., CEO of Galimedix

Farmako: Cannabis distributor to become gateway to Europe11.12.2018 10:00Pressemelding

Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research and development FRANKFURT, Germany, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal basis for cannabinoid therapies. It is the first company for medical Cannabis pursue distribution licences in multiple European countries. Fort hat, it will rely on EU-GMP certified suppliers. The German market for medical cannabis is estimated at 19.1 million euros in 2018 and at 200 million Euros by 2019. For 2028, experts expect a market volume for medical cannabis of 7.8 billion euros in Germany, an increase by a factor of 400. The number of patients for cannabinoid therapies in Germany has grown from

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom